Why is Indrayani Biotec falling/rising?

As of 01-Sep, Indrayani Biotech Ltd is experiencing a decline in its stock price, currently at Rs. 11.30, which reflects a decrease of Rs. 0.28 or 2.42%. The stock has hit a new 52-week low of Rs. 10.97 today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has fallen by 7.38%, and in the last month, it has decreased by 17.94%. The company has reported negative results for the last five consecutive quarters, with significant declines in both profit before tax and profit after tax. Additionally, the company has a weak long-term fundamental strength, indicated by a -253.18% CAGR growth in operating profits over the last five years and a high debt to EBITDA ratio of 7.34 times, which suggests low profitability and high risk.
In the broader market context, the stock's performance has been notably poor compared to the benchmark, with a year-to-date return of -68.94% against a positive return of 2.85% for the Sensex. The floriculture sector, in which Indrayani Biotech operates, has also seen a decline of 2.46%. Furthermore, there has been a decrease in participation from institutional investors, who have reduced their stake by 0.55% over the previous quarter, indicating a lack of confidence in the company's prospects. This consistent underperformance against the benchmark over the last three years, coupled with falling investor participation and negative operating profits, contributes to the stock's downward trajectory.